A nurse is reinforcing teaching a client who has a new prescription for phenytoin. The nurse should instruct the client to monitor and report which of the following adverse effects of this medication?
Diarrhea
Wrist pain
Skin rash
Metallic taste
The Correct Answer is C
A. Diarrhea:
Diarrhea is not a common side effect of phenytoin. While gastrointestinal disturbances such as nausea, vomiting, and constipation may occur, diarrhea is less common. Therefore, it is not a primary adverse effect that the nurse should instruct the client to monitor and report.
B. Wrist pain:
Wrist pain is not a common side effect of phenytoin. Side effects related to musculoskeletal issues such as joint pain, muscle weakness, or muscle twitching can occur, but wrist pain specifically is not commonly associated with phenytoin use. Therefore, it is not a primary adverse effect that the nurse should instruct the client to monitor and report.
C. Skin rash:
Skin rash is a potential adverse effect of phenytoin that should be monitored and reported. Phenytoin can cause various skin reactions, including a mild rash or more severe reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. Therefore, the nurse should instruct the client to promptly report any signs of skin rash or other skin changes.
D. Metallic taste:
Metallic taste is a common side effect of phenytoin. While it is not usually a serious adverse effect, it can be bothersome for some individuals. Therefore, the nurse should instruct the client to monitor for this side effect and report it if it occurs persistently or becomes bothersome.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. 4 hours:
This option indicates that tissue plasminogen activator (tPA) must be administered within 4 hours of the onset of stroke symptoms to be considered as a drug therapy option. tPA is a thrombolytic medication used to dissolve blood clots in ischemic stroke, and its effectiveness is highest when administered promptly after the onset of symptoms.
B. 1 hour:
Administering tPA within 1 hour of stroke onset would be extremely challenging and impractical. It typically takes time for patients to recognize stroke symptoms, seek medical attention, and undergo diagnostic evaluations before tPA administration. While time is of the essence in stroke treatment, 1 hour is too short of a timeframe for most patients to receive tPA.
C. 24 hours:
Administering tPA beyond 4.5 hours of stroke onset is generally contraindicated due to the increased risk of complications, including hemorrhagic transformation of the stroke. While there may be some extended time windows considered for certain patients under specific circumstances, such as those meeting eligibility criteria for extended thrombolytic therapy, 24 hours is outside the standard timeframe for tPA administration.
D. 8 hours:
While tPA administration within 8 hours of stroke onset may be feasible for some patients, it is beyond the standard recommended time window for optimal effectiveness. As mentioned earlier, tPA is most effective when administered within the first 3 to 4.5 hours after the onset of symptoms, with earlier administration associated with better outcomes.
Correct Answer is A
Explanation
A. "These drugs inhibit the action of acetylcholine":
This response is accurate. Anticholinergic medications work by blocking the action of acetylcholine, a neurotransmitter involved in various functions in the body, including muscle control. In Parkinson's disease, there is an imbalance between dopamine and acetylcholine, leading to motor symptoms such as tremors and rigidity. By inhibiting the action of acetylcholine, anticholinergic drugs help rebalance neurotransmitter activity and alleviate some of the motor symptoms associated with Parkinson's disease.
B. "These drugs help you urinate":
This statement is not directly related to the use of anticholinergic medications in Parkinson's disease. While some anticholinergic drugs can indeed relax the smooth muscle of the bladder and improve urinary symptoms, this is not the primary indication for their use in Parkinson's disease.
C. "These drugs will decrease your eye pressure":
While anticholinergic medications can be used to dilate the pupils and decrease intraocular pressure, this is not typically the reason for their use in Parkinson's disease. While some anticholinergic medications may have ocular effects, they are primarily used to address motor symptoms associated with Parkinson's disease.
D. "These drugs will assist in lowering your heart rate":
While some anticholinergic medications may have effects on heart rate by blocking parasympathetic nervous system activity, this is not the primary indication for their use in Parkinson's disease. The focus of anticholinergic therapy in Parkinson's disease is primarily on addressing motor symptoms rather than cardiovascular effects.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today